GLORIA

GEOMAR Library Ocean Research Information Access

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1365-2427
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Biology
    Notes: SUMMARY 1. Macrophyte abundance and distribution was assessed in a chain of six interconnected lakes (all with the same flooding frequency) in the Arctic, where increasing distance from the Mackenzie River channel resulted in a gradient of water transparency (‘chain-set’ lakes), and in a group of 26 spatially discrete lakes where increasing frequency and duration of lake flooding with river water (controlled by sill height) also resulted in a transparency gradient (‘sill-set’ lakes).2. Among the chain-set lakes, above-ground macrophyte biomass increased from 0 to 1000 g m−2 with increasing water transparency. Among the sill-set lakes, the transparency gradient among the lakes was less well defined and the relations with biomass were more varied. A decrease in flooding was associated with increasing water transparency and an increasing biomass of macrophytes from about 0 to over 2000 g m−2. For a specific flood frequency, however, the effect of flooding was much greater when lakes were directly connected to a river channel than when floodwaters flowed first through an intervening lake. Among infrequently flooded lakes the effect of flooding on water transparency and biomass was negligible.3. Among relatively clear lakes in both sets of lakes, biomass increased with increasing water transparency and decreasing lake depth. Among relatively turbid lakes, however, biomass increased with the combined effect of increasing water colour (decreasing water transparency) and increasing lake water depth. The increases in biomass with increasing water colour (coloured dissolved organic matter) and increasing depth, which together result in reduced light at the bed, may be explained by reduced exposure to ultra violet light.4. An average light attenuation of 1.3 m−1 (Secchi depth about 1 m) over the growing season appears to represent a threshold water transparency which, in combination with water depths early in the growing season, is consistent with a light supply on the bed required for growth of the common macrophytes in lakes of the Mackenzie Delta. However, a comparison with other systems indicates that macrophytes among lakes of the Mackenzie Delta grow deeper, for a given level of transparency, than is reported in lakes at lower latitude, despite the lower sun angles and increased reflectivity of water surfaces in the arctic.5. A complete accounting of water transparency (at PAR and UV wavelengths), lake depth, summer sun angle and duration of sunlight may be necessary to explain patterns of macrophyte growth among lakes across a full range of latitudes.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    [s.l.] : Nature Publishing Group
    Nature 226 (1970), S. 1056-1056 
    ISSN: 1476-4687
    Source: Nature Archives 1869 - 2009
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Notes: [Auszug] Bovine immunoglobulins G1 and G2 were prepared from normal serum by DEAE-cellulose chromatography using gradient elution4. A sample of each immunoglobulin was reduced with 5 mM dithiothreitol in aqueous solution and alkylated with iodo[2-14C]acetic acid5. Light and heavy polypeptide chains were ...
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1476-4687
    Source: Nature Archives 1869 - 2009
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Notes: [Auszug] The precarious condition of the world's fisheries is making ever-greater demands of the scientific assessment of fish stocks. Traditional assessments that rely on commercial catch statistics can have major shortcomings (as shown, for example, by the collapse of Canada's northern cod ...
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Archives of microbiology 125 (1980), S. 83-87 
    ISSN: 1432-072X
    Keywords: Aeromonas hydrophila ; Glucan ; Structure ; Utilization ; Fish pathogen
    Source: Springer Online Journal Archives 1860-2000
    Topics: Biology
    Notes: Abstract Glucans from the fish pathogen Aeromonas hydrophila have been extracted andpurified by a method utilizing phenol/water followed by sodium deoxycholate rather than the traditional sodium hydroxide extraction. Presence of substantial amounts of these glucans was shown to be dependant on whether or not the substrate contained dextrose, a point which had import because of the low carbohydrate environment in which this species must survive and multiply. These glucans, produced in the log phase, were utilized during the later growth period. The structures of the two purified glucans were examined by methylation analysis, periodate oxidation, and enzymatic degradation. The results indicated that A. hydrophila under low-carbohydrate growth conditions produced two similar but distinguishable α1→4 linked glucans substituted α1→6 by single monosaccharide residues or short chains to give an amylopectinglycogen type of polysaccharide.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Publication Date: 2014-04-04
    Description: The JAK1/JAK2 inhibitor ruxolitinib produced significant reductions in splenomegaly and symptomatic burden and improved survival in patients with myelofibrosis (MF), irrespective of their JAK2 mutation status, in 2 phase III studies against placebo (COMFORT-I) and best available therapy (COMFORT-II). We performed a comprehensive mutation analysis to evaluate the impact of 14 MF-associated mutations on clinical outcomes in 166 patients included in COMFORT-II. We found that responses in splenomegaly and symptoms, as well as the risk of developing ruxolitinib-associated anemia and thrombocytopenia, occurred at similar frequencies across different mutation profiles. Ruxolitinib improved survival independent of mutation profile and reduced the risk of death in patients harboring a set of prognostically detrimental mutations ( ASXL1, EZH2, SRSF2, IDH1/2 ) with an hazard ratio of 0.57 (95% confidence interval: 0.30-1.08) vs best available therapy. These data indicate that clinical efficacy and survival improvement may occur across different molecular subsets of patients with MF treated with ruxolitinib.
    Keywords: Free Research Articles, Myeloid Neoplasia, Brief Reports, Clinical Trials and Observations
    Print ISSN: 0006-4971
    Electronic ISSN: 1528-0020
    Topics: Biology , Medicine
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Publication Date: 2014-05-31
    Description: Purpose: Fibroblast growth factor (FGF) signaling regulates tumor growth and vascularization and partly mediates antiangiogenic escape from VEGF receptor (VEGFR) inhibitors. Dovitinib (TKI258) is a tyrosine kinase inhibitor (TKI) that inhibits FGF receptor (FGFR), VEGFR, and platelet-derived growth factor receptor, which are known drivers of antiangiogenic escape, angiogenesis, and tumor growth in renal cell carcinoma (RCC). Experimental Design: Patients with advanced or metastatic RCC were treated with oral dovitinib 500 mg/day (5-days-on/2-days-off schedule). The study population was enriched for patients previously treated with a VEGFR TKI and an mTOR inhibitor. Results: Of 67 patients enrolled, 55 patients (82.1%) were previously treated with ≥1 VEGFR TKI and ≥1 mTOR inhibitor (per-protocol efficacy set). The 8-week overall response rate and disease control rate in this population were 1.8% and 52.7%, respectively. Disease control rate during the entire study period was 56.4% (50.9% ≥4 months). Median progression-free survival and overall survival in the entire population were 3.7 and 11.8 months, respectively. Pharmacodynamic analyses demonstrated dovitinib-induced inhibition of VEGFR (as determined by increased levels of placental growth factor and decreased levels of soluble VEGFR2) and FGFR (as determined by increased FGF23 serum measures). The most frequently reported treatment-related adverse events of all grades included nausea (65.7%), diarrhea (62.7%), vomiting (61.2%), decreased appetite (47.8%), and fatigue (32.8%). Conclusion: Dovitinib was shown to be an effective and tolerable therapy for patients with metastatic RCC who had progressed following treatment with VEGFR TKIs and mTOR inhibitors. Clin Cancer Res; 20(11); 3012–22. ©2014 AACR .
    Print ISSN: 1078-0432
    Electronic ISSN: 1557-3265
    Topics: Medicine
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Publication Date: 2012-04-25
    Description: Background: AT9283 is an inhibitor of aurora kinases A and B with antitumor activity in preclinical models. This a First in Human phase I study assessed the safety, tolerability, pharmacokinetic and pharmacodynamic properties and preliminary efficacy of AT9283. Patients and methods: Patients with advanced tumors received AT9283 as a continuous central venous infusion over 3 days in cohorts of three to six patients starting at 1.5 mg/m 2 /day (equivalent to 4.5 mg/m 2 /72 h). The oral bioavailability of AT9283 was assessed in a cohort of seven patients. Pharmacodynamic analysis of biomarkers included phosphorylation of histone H3 on serine 10, proliferating cell nuclear antigen, Ki67, M30 and M65 in skin and plasma. Results: Forty patients were included in all analyses. AT9283 was generally well tolerated with main toxic effects of reversible dose-related myelosuppression, gastrointestinal disturbance, fatigue and alopecia. The dose-limiting toxicity of AT9283 was grade 3 febrile neutropenia in two patients at 36 mg/m 2 /72 h and the maximum tolerated dose (MTD) was established at 27 mg/m 2 /72 h. Systemic exposure was dose proportional. The mean oral bioavailability of a 0.9 mg/m 2 dose was 29.4% (range 11.2%–36.7%). Pharmacodynamic analyses indicated antiproliferative and apoptotic activity of AT9283. Four patients with esophageal, non-small-cell lung cancer ( n = 2) and colorectal cancer demonstrated RECIST stable disease ≥6 months. Conclusion: AT9283 was well tolerated up to the MTD of 27 mg/m 2 /72 h. AT9283 is currently assessed in phase II trials.
    Print ISSN: 0923-7534
    Electronic ISSN: 1569-8041
    Topics: Medicine
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...